News Headline Summary

Bristol-Myers (BMY) Hepatitis C combo therapy shows promise in study

Reaction details:

- BMY pops to the upside in reaction to this headline, moving higher by 0.3%; trades USD 32.03 last.

Print 20:30, 12 Nov 2012 - US Equities - Source: Newswires